Life Science #Investing News is educating and helping investors make better investment decisions.
Joined October 2012
- Tweets8.5K
- Following2.7K
- Followers4.7K
- Likes96
Mayo Clinic built an AI model that predicts pancreatic cancer risk up to 3 years before diagnosis using standard health records. A 50%+ risk score meant an 88% chance of diagnosis within a year. Details: investingnews.com/ai-predict…
Telix is acquiring Germany's ITM for $1.65B, gaining the world's only commercial-scale producer of lutetium-177, a key cancer treatment isotope. Details: investingnews.com/telix-inks…
INN Life Science retweeted
Pharma is one of the strongest sectors of 2026 and these 5 Canadian stocks are leading the charge. Full breakdown: investingnews.com/best-canad…
INN Life Science retweeted
. @EliLillyandCo 's valuation just topped $1 trillion on GLP-1 sales, while @novonordisk is down 8% YTD after two failed drug trials. Here's what's driving the split: investingnews.com/eli-lilly-…
INN Life Science retweeted
Humanoid robots just performed live surgery. AI agents are cutting clinical trial costs by millions per study. Here's where the near-term ROI is, and where the moonshots sit: investingnews.com/clinical-a…
Disseminated on behalf of @BriaCell (TSX:BCT,NASDAQ:BCTX).
Nine of 25 patients treated with Bria-IMT since 2022 remain alive, surviving 18 to 47 months in a population where median survival is typically under 12 months. See the data behind BriaCell's immunotherapy approach. Full breakdown: lnkd.in/giWcn4wE
Disseminated on behalf of @BriaCell (TSX:BCT,NASDAQ:BCTX). BriaCell's Bria-IMT pivotal trial earned a rare spot on Nature Medicine's list of eleven clinical trials shaping medicine in 2026, with 52% of patients in the latest cohort reaching the one-year survival mark. See what's behind the recognition. Full breakdown: investingnews.com/beyond-the…
The designation fast-tracks development and review. Read more: investingnews.com/eli-lilly-…
EliLilly has acquired AtaiBeckley for US$2.8 billion, gaining control of BPL-003, a DMT-derived nasal spray in Phase 3 trials for treatment-resistant depression with Phase 3 results expected in 2029. Read more: investingnews.com/eli-lilly-…
Zymeworks has agreed to acquire Theravance Biopharma for US$929 million in cash, gaining a 35 percent US profit share in Yupelri, the only once-daily nebulized COPD treatment approved by the FDA.Read more: investingnews.com/zymeworks-…
Merck KGaA has agreed to acquire Bio-Techne for US$11.3 billion in cash, a 36 percent premium and the company's largest deal in a decade. Bio-Techne supplies proteins, antibodies and instruments used in drug discovery and gene therapy globally. Shares surged 20 percent on the news. Read more: investingnews.com/merck-kgaa…
The global stem cell therapy market is set for major growth. 🌱💉 Check out the 10 top stem cell stocks on the NASDAQ poised to benefit: #StemCells #Biotech #NASDAQ #Investing #LifeScienceInvesting investingnews.com/daily/life…
Biotech's booming—but you don't have to bet on just one stock. 🔬📈 Biotech ETFs offer diversified exposure to the sector in a single trade. Here are 5 to keep on your radar: investingnews.com/daily/life… #Biotech #ETFs #Investing #HealthcareStocks #LifeScienceInvesting
The pharma industry drives the life sciences sector, powering the development & production of most prescription drugs. 💊
👉 Explore the biggest pharmaceutical stocks to watch! investingnews.com/daily/life…
#LifeScience #PharmaceuticalInvesting
. @TeamRadiopharm is emerging as a key player in the booming radiopharmaceutical space, backed by a cutting-edge tech platform and a robust clinical pipeline. A high-potential opportunity in precision oncology. 🔬📈 #Radiopharmaceuticals #Biotech #RADX #Investing investingnews.com/stocks/asx…
In Q2, #biotech and #pharma navigated policy pressures, AI's transformative impact, and #tariff headwinds — all weighing on M&A and reshaping market dynamics. #HealthcareForecast #BiotechInvesting #PharmaceuticalInvesting investingnews.com/healthcare…
AI is revolutionizing #healthcare! From personalized medicine and early diagnostics to surgical robots, discover how #AI is reshaping the future of health, addressing challenges, and attracting investor attention. #AIinHealthcare #HealthTech #FutureofMedicine investingnews.com/artificial…
💊 #Pharmastocks face pressure from price caps, fading COVID-19 vaccine demand & market turmoil — but long-term drivers like rising cancer & chronic disease rates remain. See what's driving the top NASDAQ small-cap pharma gainers.
#Pharma #Investing #NASDAQ #LifeScienceInvesting #PharmaceuticalInvesting
investingnews.com/daily/life…
